相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of VU0467485/AZ13713945: An M4 PAM Evaluated as a Preclinical Candidate for the Treatment of Schizophrenia
Michael R. Wood et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Best practice in the management of behavioural and psychological symptoms of dementia
Olivier Pierre Tible et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2017)
Discovery of a novel 2,4-dimethylquinoline-6-carboxamide M4 positive allosteric modulator (PAM) chemotype via scaffold hopping
Madeline F. Long et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Challenges in the development of an M4 PAM preclinical candidate: The discovery, SAR, and in vivo characterization of a series of 3-aminoazetidine-derived amides
James C. Tarr et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Optimization of M4 positive allosteric modulators (PAMs): The discovery of VU0476406, a non-human primate in vivo tool compound for translational pharmacology
Bruce J. Melancon et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Classics in Chemical Neuroscience: Xanomeline
Aaron M. Bender et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Challenges in the development of an M4 PAM in vivo tool compound: The discovery of VU0467154 and unexpected DMPK profiles of close analogs
Michael R. Wood et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Quantitative analysis of receptor allosterism and its implication for drug discovery
Rumin Zhang et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
Selective Activation of M4 Muscarinic Acetylcholine Receptors Reverses MK-801-Induced Behavioral Impairments and Enhances Associative Learning in Rodents
Michael Bubser et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Setting expectations in molecular optimizations: Strengths and limitations of commonly used composite parameters
Michael D. Shultz
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Probing Structural Requirements of Positive Allosteric Modulators of the M4 Muscarinic Receptor
Tracey Huynh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Discovery of N-(4-methoxy-7-methylbenzo[d]thiazol-2-yl)isonicatinamide, ML293, as a novel, selective and brain penetrant positive allosteric modulator of the muscarinic 4 (M4) receptor
James M. Salovich et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
SAR Matrices: Automated Extraction of Information-Rich SAR Tables from Large Compound Data Sets
Anne Mai Wassermann et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Muscarinic and Nicotinic Acetylcholine Receptor Agonists and Allosteric Modulators for the Treatment of Schizophrenia
Carrie K. Jones et al.
NEUROPSYCHOPHARMACOLOGY (2012)
THE ANTIPSYCHOTIC POTENTIAL OF MUSCARINIC ALLOSTERIC MODULATION
Thomas M. Bridges et al.
DRUG NEWS & PERSPECTIVES (2010)
Effect of P-glycoprotein-mediated efflux on cerebrospinal fluid concentrations in rhesus monkeys
Cuyue Tang et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Attenuation of amphetamine-induced activity by the non-selective muscarinic receptor agonist, xanomeline, is absent in muscarinic M4 receptor knockout mice and attenuated in muscarinic M1 receptor knockout mice
Marie L. Woolley et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Enhanced SAR Maps: Expanding the Data Rendering Capabilities of a Popular Medicinal Chemistry Tool
Jeremy Kolpak et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Utility of unbound plasma drug levels and P-glycoprotein transport data in prediction of central nervous system exposure
H. He et al.
XENOBIOTICA (2009)
Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia
Anantha Shekhar et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Centrally Active Allosteric Potentiators of the M4 Muscarinic Acetylcholine Receptor Reverse Amphetamine-Induced Hyperlocomotor Activity in Rats
Ashley E. Brady et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia
W. Y. Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Effect of P-glycoprotein-mediated efflux on cerebrospinal fluid/plasma concentration ratio
T Ohe et al.
DRUG METABOLISM AND DISPOSITION (2003)
Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system
FP Bymaster et al.
NEUROCHEMICAL RESEARCH (2003)
分享论文
